Global Structural Heart Devices Market Research Report By Device Type (Transcatheter Aortic Valve Replacement, Mitral Valve Repair Devices, Left Atrial Appendage Closure Devices, Transcatheter Pulmonary Valve), By Procedure Type (Minimally Invasive, Surgical, Percutaneous), By Indication (Aortic Stenosis, Mitral Regurgitation, Heart Failure, Pulmonary Valve Stenosis), By End User (Hospitals, Ambulatory Surgical Centers, Cardiology Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast

Structural Heart Devices Market Overview

As per MRFR analysis, the Structural Heart Devices Market Size was estimated at 6.38 (USD Billion) in 2023.The Structural Heart Devices Market Industry is expected to grow from 6.72(USD Billion) in 2024 to 11.8 (USD Billion) by 2035. The Structural Heart Devices Market CAGR (growth rate) is expected to be around 5.25% during the forecast period (2025 - 2035).

Key Structural Heart Devices Market Trends Highlighted

A rising incidence of cardiovascular disorders and a growing aging population mostly drive significant developments in the Global Structural Heart Devices Market. Growing knowledge about heart health is driving more people to look for sophisticated therapy possibilities. Moreover, developments in technology are enhancing gadget safety and effectiveness, which is causing increasing acceptance by healthcare professionals.

A major factor driving the rise of minimally invasive surgeries is these methods' alignment with patient expectations for less intrusive treatments, as they provide faster recovery rates and lower hospital stays. Among the possibilities to investigate are those for growth in developing countries where heart disease rates are increasing.

These areas are seeing better access to innovative medical technology and healthcare infrastructure, which is setting a good environment for the expansion of structural cardiac devices. Increasing funding in research and development also helps to drive innovation by enabling the creation of next-generation gadgets that more precisely meet various patient demands. Trends in recent decades include a significant move toward personalized treatment, where gadgets are customized to fit specific player circumstances. Improvements in diagnostic techniques allowing better cardiac disease characterization help this change by providing more focused therapies from healthcare professionals.

Digital health technologies are also becoming increasingly integrated into structural heart disease management, improving patient monitoring and follow-up treatment. These trends, taken together, point to a dynamic environment for the Global Structural Heart Devices Market, stressing the necessity of ongoing vigilance in meeting the changing demands of patients and healthcare professionals.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Structural Heart Devices Market Drivers

Increasing Prevalence of Cardiovascular Diseases

Rising rates of cardiovascular diseases among the top causes of morbidity and death worldwide are driving notable expansion of the Global Structural Heart Devices Market Industry. The World Health Organization estimates that over 31% of all worldwide fatalities are caused by cardiovascular illnesses or about 17.9 million people annually. This disturbing number highlights the pressing need for creative structural cardiac devices to control congenital heart abnormalities and valve disorders.

Well-known institutions such as the American Heart Association and the European Society of Cardiology have been pushing developments in heart health to influence healthcare policy to fit the rising need for structural heart treatments. Therefore, the rising emphasis on early detection and treatment of heart-related disorders is likely to greatly increase the sales of Structural Heart Devices in the Global market.

Technological Advancements in Device Design and Functionality

Notable developments in the design and use of structural heart devices are driving ahead the Global Structural Heart Devices Market Industry. Innovations like transcatheter aortic valve replacement and left atrial appendage closure devices have transformed the treatment of heart disorders by reducing invasiveness and enhancing patient outcomes. The U.S. Food and Drug Administration claims that during the last decade, approval rates for cardiovascular devices have consistently risen, driven by numerous innovations being launched yearly.

Companies like Medtronic and Edwards Lifesciences are leading these technical developments. They concentrate mostly on Research and development to improve the performance of cardiac devices. Such developments are likely to greatly help the market expand and are necessary to handle the rising worldwide burden of cardiovascular illnesses.

Aging Population and Growing Demand for Cardiac Procedures

Another important factor for the Global Structural Heart Devices Market Industry is the aging world population. Aging people are increasingly vulnerable to heart disease, which calls for different cardiac treatments and procedures. Almost tripling from 1 billion in 2019, the United Nations estimates that the worldwide population aged 60 years and older will reach 2.1 billion by 2050. Countries such as Japan, Italy, and Germany, which have some of the largest proportions of older people, are seeing a growing need for structural heart operations.

Healthcare systems in these areas are changing to fit this expanding population, thereby enabling the creation and distribution of creative cardiac devices and so greatly influencing market expansion.

Structural Heart Devices Market Segment Insights

Structural Heart Devices Market Device Type Insights

The Global Structural Heart Devices Market, specifically within the Device Type segment, showcases significant growth and varied demand across its components. In 2024, the entire market is valued at approximately 6.72 USD Billion, with strong projections hinting towards an increase to around 11.8 USD Billion by 2035. 

The analysis of the structural heart devices reveals notable sub-segments, with Transcatheter Aortic Valve Replacement leading the way, holding a valuation of 2.5 USD Billion in 2024 and expected to rise impressively to 4.35 USD Billion by 2035.This reflects its major role in treating aortic stenosis, which is becoming increasingly vital in the aging population. Following this, the Mitral Valve Repair Devices segment holds a market value of 1.8 USD Billion in 2024, which is projected to grow to approximately 3.1 USD Billion by 2035, demonstrating the critical enhancements in mitral valve procedures that are advancing patient outcomes. 

The Left Atrial Appendage Closure Devices segment also plays a significant role, valued at 1.2 USD Billion in 2024, demonstrating its potential to help mitigate stroke risk in patients with atrial fibrillation.By 2035, this segment is projected to rise to 2.05 USD Billion, thus highlighting its growing importance in specific patient populations. Meanwhile, the Transcatheter Pulmonary Valve segment is valued at 1.22 USD Billion in 2024 and is anticipated to reach 2.5 USD Billion by 2035, signifying its essential role in treating pulmonary valve disease, particularly in pediatric patients. 

These sub-segments collectively underscore the importance and dominance of various structural heart devices within the overall market, driven by innovative advances in technology and increasing clinical success rates that continue to expand their application.Overall, the market growth is supported by rising incidences of heart diseases globally and advancements in minimally invasive surgical procedures, contributing significantly to the Global Structural Heart Devices Market revenue growth. With growing awareness and improved healthcare infrastructure, new opportunities are emerging, encouraging investments in further technological innovations within these specific device types, resulting in enhanced patient care worldwide. 

The Global Structural Heart Devices Market data demonstrates a clear trajectory of growth across all segments, reflecting the increasing adoption of these critical devices in clinical settings and highlighting opportunities for ongoing research and development in this vital area of cardiovascular care.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Structural Heart Devices Market Procedure Type Insights

The Global Structural Heart Devices Market is projected to experience robust growth driven by diverse procedures, notably through the Procedure Type segment. In 2024, the market is expected to be valued at 6.72 USD Billion, with significant contributions from a variety of treatment modalities. This segment encompasses Minimally Invasive, Surgical, and Percutaneous procedures, each playing a vital role in the market dynamics. 

Minimally Invasive procedures are gaining traction due to their associated lower recovery times and reduced hospital stays, making it a preferred choice among patients and healthcare providers.Surgical procedures, while traditionally more complex, remain essential for certain patient demographics, ensuring they continue to hold a significant share in treating structural heart conditions. Meanwhile, Percutaneous techniques are emerging as a dynamic option, offering advantages in patient accessibility and safety. 

As global healthcare systems increasingly prioritize patient-centered care and cost-effectiveness, the Procedure Type segmentation illustrates the adaptability and innovation within the Global Structural Heart Devices Market.The market is poised for notable advancements as technological enhancements facilitate more streamlined and efficient procedures, further encouraging its expansion on a global scale.

Structural Heart Devices Market Indication Insights

The Global Structural Heart Devices Market is poised for significant growth as it addresses various cardiovascular conditions through specialized technologies. In 2024, the market is set to be valued at 6.72 USD Billion, reflecting the increasing need for effective treatments for structural heart issues. 

Various indications such as Aortic Stenosis and Mitral Regurgitation demonstrate a strong dominance within the market due to their high prevalence and impact on patient quality of life. Heart Failure also represents a substantial segment, driven by rising diagnosis and treatment needs globally, while Pulmonary Valve Stenosis showcases its relevance in pediatric and adult populations alike.The Global Structural Heart Devices Market segmentation highlights the diversity in treatment methodologies and innovation, ensuring a comprehensive portfolio of solutions for healthcare providers. 

As technological advancements evolve rapidly, market growth will be supported by increasing adoption rates, an aging population, and a focus on improving patient outcomes in cardiovascular health. Market dynamics suggest that the continued development of these targeted therapies holds a pivotal role in enhancing the efficiency of diagnoses and patient management in the Global marketplace.

Structural Heart Devices Market End User Insights

The Global Structural Heart Devices Market is poised for significant growth as it approaches a valuation of 6.72 USD Billion in 2024. It is projected to reach 11.8 USD Billion by 2035, showcasing a steady increase driven by advancements in medical technologies and rising incidences of structural heart diseases. 

The End User segment comprises Hospitals, Ambulatory Surgical Centers, and Cardiology Clinics, with Hospitals playing a crucial role due to their comprehensive care capabilities and access to advanced diagnostic and treatment options. Ambulatory Surgical Centers are gaining traction as they offer cost-effective and efficient care alternatives, addressing the growing demand for less invasive procedures.Furthermore, Cardiology Clinics are centered on specialized care, enhancing patient outcomes through focused services and specialized expertise. 

The combination of an aging population, increasing healthcare expenditures, and technological innovations drives the market growth, while challenges such as regulatory hurdles and reimbursement issues may pose minor obstacles. The Global Structural Heart Devices Market data reflects a diverse range of services and solutions tailored to patients' needs, emphasizing an integrated approach to healthcare delivery in the global landscape.

Structural Heart Devices Market Regional Insights

The Global Structural Heart Devices Market is extensively segmented on a regional basis, with North America leading the way. In 2024, North America is projected to hold a significant market valuation of 3.1 USD Billion, increasing to 5.2 USD Billion by 2035, demonstrating its majority holding in the overall market landscape. 

Europe follows closely, valued at 2.2 USD Billion in 2024 and expected to reach 3.8 USD Billion by 2035, reflecting its robust healthcare infrastructure and aging population driving demand. The APAC region is valued at 0.9 USD Billion in 2024, with growth anticipated at 1.6 USD Billion in 2035, supported by rising health awareness and improvements in medical technology.South America, while smaller at 0.3 USD Billion in 2024, is projected to grow to 0.5 USD Billion by 2035, indicating a developing market landscape. 

Meanwhile, the MEA region, valued at 0.22 USD Billion in 2024 and expected to touch 0.3 USD Billion by 2035, highlights the emerging opportunities due to increasing adoption of advanced healthcare technologies. The variations among these regions point to a mix of established markets and developing landscapes, each presenting unique challenges and growth drivers in the Global Structural Heart Devices Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Structural Heart Devices Market Key Players and Competitive Insights

The Global Structural Heart Devices Market has witnessed significant advancements and competitive dynamics in recent years, driven by the rising incidence of heart diseases and the growing demand for minimally invasive surgical procedures. This sector plays a crucial role in cardiovascular health by offering devices that treat various structural heart conditions, including valvular heart diseases and congenital heart defects. 

With a variety of stakeholders ranging from established medical device manufacturers to emerging startups, competitive strategies are often centered around innovation, technological advancements, and strategic partnerships. The evolving landscape is further influenced by regulatory approvals, pricing strategies, and the comprehensive focus on patient outcomes, which drive companies to enhance their product offerings and services to gain market foothold.

Edwards Lifesciences has established a formidable presence in the Global Structural Heart Devices Market, recognized for its pioneering innovations and high-quality products. The company excels in the development of transcatheter heart valves and is a leader in the rapidly growing segment of transcatheter aortic valve replacement. Edwards Lifesciences builds its strengths on a solid foundation of robust clinical evidence, in-depth research and development capabilities, and strategic collaborations with healthcare providers. These elements not only enhance its credibility in the market but also foster trust among patients and caregivers. 

The company's commitment to innovation ensures it remains competitive, providing customized solutions that cater to the evolving needs of patients suffering from heart conditions.LivaNova also demonstrates strong capabilities within the Global Structural Heart Devices Market, focusing on providing high-performance products and solutions that improve patient outcomes. The company’s notable key offerings include its innovative mitral and tricuspid valve repair devices, which are supported by extensive clinical trials that underline their efficacy and safety. 

LivaNova's market presence is marked by its strategic mergers and acquisitions, allowing the company to enhance its product portfolio and expand its reach in global markets. The brand is known for its ability to integrate new technologies rapidly, maintaining a competitive edge while fostering partnerships that support comprehensive cardiovascular care. LivaNova’s strengths stem from its diversified product line and commitment to advancing minimally invasive procedures, thus catering not only to existing needs but also paving the way for future innovations in the structural heart space.

Key Companies in the Structural Heart Devices Market Include

• Edwards Lifesciences


• LivaNova


• Johnson and Johnson


• Terumo Corporation


• Abbott


• B. Braun Melsungen


• FastTrack


• Merit Medical


• ReCor Medical


• SentreHEART


• Medtronic


• Avinger


• Penumbra


• Cardinal Health


• Boston Scientific

Structural Heart Devices Market Industry Developments

The Global Structural Heart Devices Market has witnessed significant developments recently, particularly with major players like Edwards Lifesciences, Medtronic, and Boston Scientific actively expanding their product portfolios. In August 2023, Edwards Lifesciences announced the successful launch of its innovative TAVR technology, aimed at enhancing valve replacement procedures and meeting growing patient needs. 

Johnson and Johnson has also increased its focus on minimally invasive techniques, reflecting a broader industry trend toward less invasive procedures. Notably, in September 2023, Boston Scientific acquired a leading start-up specializing in transcatheter therapies to strengthen its position in the heart disease treatment segment. The market has seen a surge in demand driven by an aging population and a rise in cardiovascular diseases, prompting organizations like the American Heart Association to advocate for more advanced treatments. 

Furthermore, regulatory agencies across the globe are increasingly supporting the development of new devices, enhancing the market's growth potential. In the last few years, the market has achieved significant valuation increases, estimated to exceed USD 15 billion by 2025, as firms invest heavily in Research and Development to innovate and address unmet clinical needs.

Structural Heart Devices Market Segmentation Insights

• 
  

  Structural Heart Devices Market Device Type Outlook

  
  


• Transcatheter Aortic Valve Replacement


• Mitral Valve Repair Devices


• Left Atrial Appendage Closure Devices


• Transcatheter Pulmonary Valve


• 
  

  Structural Heart Devices Market Procedure Type Outlook

  
  


• Minimally Invasive


• Surgical


• Percutaneous


• 
  

  Structural Heart Devices Market Indication Outlook

  
  


• Aortic Stenosis


• Mitral Regurgitation


• Heart Failure


• Pulmonary Valve Stenosis


• 
  

  Structural Heart Devices Market End User Outlook

  
  


• Hospitals


• Ambulatory Surgical Centers


• Cardiology Clinics


• 
  

  Structural Heart Devices Market Regional Outlook

  
  


• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	6.38(USD Billion)
MARKET SIZE 2024	6.72(USD Billion)
MARKET SIZE 2035	11.8(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.25% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Edwards Lifesciences, LivaNova, Johnson and Johnson, Terumo Corporation, Abbott, B. Braun Melsungen, FastTrack, Merit Medical, ReCor Medical, SentreHEART, Medtronic, Avinger, Penumbra, Cardinal Health, Boston Scientific
SEGMENTS COVERED	Device Type, Procedure Type, Indication, End User, Regional
KEY MARKET OPPORTUNITIES	Growing aging population, Rising prevalence of heart diseases, Advancements in minimally invasive procedures, Increased healthcare expenditure, Expanding patient awareness and education
KEY MARKET DYNAMICS	aging population, increasing prevalence of heart diseases, technological advancements in devices, growing healthcare expenditure, rising awareness of treatment options
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA